PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer

Autor: Aya Ohtsubo, Miyuki Sato, Toshiyuki Koya, Masashi Arita, Satoshi Shoji, Satoshi Hokari, Satoshi Watanabe, Ko Sato, Nobumasa Aoki, Toshiya Fujisaki, Ryo Suzuki, Toshiaki Kikuchi, Kosuke Ichikawa, Miho Takahashi, Yuki Sekiya, Yuko Abe, Masachika Hayashi, Yasuyoshi Ohshima, Koichiro Nozaki, Rie Kondo, Yu Saida
Rok vydání: 2021
Předmět:
Zdroj: Cancer Immunology, Immunotherapy. 71:1357-1369
ISSN: 1432-0851
0340-7004
Popis: Lymphodepleting cytotoxic regimens enhance the antitumor effects of adoptively transferred effector and naive T cells. Although the mechanisms of antitumor immunity augmentation by lymphodepletion have been intensively investigated, the effects of lymphodepletion followed by T cell transfer on immune checkpoints in the tumor microenvironment remain unclear. The current study demonstrated that the expression of immune checkpoint molecules on transferred donor CD4+ and CD8+ T cells was significantly decreased in lymphodepleted tumor-bearing mice. In contrast, lymphodepletion did not reduce immune checkpoint molecule levels on recipient CD4+ and CD8+ T cells. Administration of anti-PD-1 antibodies after lymphodepletion and adoptive transfer of T cells significantly inhibited tumor progression. Further analysis revealed that transfer of both donor CD4+ and CD8+ T cells was responsible for the antitumor effects of a combination therapy consisting of lymphodepletion, T cell transfer and anti-PD-1 treatment. Our findings indicate that a possible mechanism underlying the antitumor effects of lymphodepletion followed by T cell transfer is the prevention of donor T cell exhaustion and dysfunction. PD-1 blockade may reinvigorate exhausted recipient T cells and augment the antitumor effects of lymphodepletion and adoptive T cell transfer.
Databáze: OpenAIRE